Citadel Advisors’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-70,701	Closed	-$926	–	7069
2024 Q3	$926	Buy	70,701 +200	+0.3%	+$3	﹤0.01%	5625
2024 Q2	$2.97K	Buy	70,501 +54,628	+344%	+$2.3K	﹤0.01%	5632
2024 Q1	$825	Buy	+15,873	New	+$825	﹤0.01%	5930